Peter Altman

Company: BioCardia
Job title: Chief Executive Officer
Seminars:
Clinical Development Synergies of Autologous and Allogeneic Bone Marrow Derived Cell Therapies for Ischemic Heart Failure 1:30 pm
CardiAMP Cell Therapy for Ischemic HFrEF Phase III Trial CardiALLO NK1R+ MSC Therapy for Ischemic HFrEF Phase I/II TrialRead more
day: Conference Day 1